Qualtran provides critical clinical research outsourcing services to the pharmaceutical, biomedical and medical device industries.

Our expertise covers a full range of services related to Phase II, Phase III, and Phase IV pharmaceutical trials, 510K, PMA and HDE (humanitarian device exemption) medical device trials, and similar clinical studies for US and international regulatory submission. Qualtran has successfully managed projects for clients needing everything from planning and monitoring to analysis and document preparation. At Qualtran, we believe that each client is unique, all clinical trials are different, and success hinges on flexibility. Qualtran is able to deliver customized services to each of our clients depending upon their strategic goals.